Why Fatty Liver Happens in Menopause — The PEMT Ceiling

When the Labs Don’t Match the Effort

You eat well. You’re deliberate about it. Then a routine ultrasound or blood panel flags something unexpected: fatty liver. Or your liver enzymes are running slightly elevated with no clear explanation. You haven’t changed your diet. You’re not drinking. Nothing in the clinical picture accounts for it.

The standard response is dietary — eat less fat, lose weight, come back in six months. You may have already tried that. The fat accumulation persists at a level that doesn’t match your intake. If you’re also supplementing vitamin D and watching that number refuse to budge, or gaining abdominal weight that has no relationship to what you’re eating, the pattern starts to feel like your body isn’t responding to the rules it used to follow.

Your liver’s ability to export fat depends on phosphatidylcholine — a molecule it manufactures using an enzyme called PEMT. PEMT is upregulated by estrogen. Post-menopause, that manufacturing drops. The dietary approach that held before menopause was partially underwritten by what estrogen was doing inside your cells. That’s a different question than how much fat you’re eating.

If This Is You

If a routine scan or blood panel flagged fatty liver and your diet doesn’t account for it…
If your liver enzymes are running slightly elevated and no one has a clear explanation why…
If you spend real time outside and your vitamin D still runs low on labs — not incidental sun, intentional exposure…
If you’ve been supplementing vitamin D for months and your levels barely moved, or moved once and flatlined…
If you’re gaining abdominal weight that doesn’t track your intake — specifically since menopause…
If you’ve tried liver support protocols and something in the picture still won’t shift…

Your liver’s ability to clear fat and transport fat-soluble nutrients changed when your estrogen did.

Why Nutritional Support Has a Ceiling: The PEMT Mechanism

PEMT — phosphatidylethanolamine N-methyltransferase — is the enzyme that synthesizes phosphatidylcholine endogenously. Phosphatidylcholine (PC) is the most abundant phospholipid in every cell membrane, the molecule that packages fat into VLDL particles for export from the liver, and a structural component of bile that keeps fat-soluble nutrients moving into circulation.

What distinguishes PEMT from most metabolic enzymes is its estrogen dependence. The PEMT gene promoter contains estrogen response elements — estrogen directly upregulates PEMT transcription. Premenopausal women synthesize endogenous PC at a rate that covers a meaningful share of daily requirement. Premenopausal women require significantly less dietary choline than men or postmenopausal women — the gap being made up by endogenous synthesis. Post-menopause, that synthesis drops. Dietary choline requirements rise to compensate. The nutritional protocol that held pre-menopause was partially underwritten by estrogen, not by diet alone.

The supplementation addressed what was missing. It never had instructions for what was producing it.

Where the PEMT Mechanism Breaks Down

Phosphatidylcholine deficit impairs VLDL fat export. Fat packaged for export from the liver as VLDL requires PC. When PC production drops, so does the liver’s ability to clear accumulated fat. The abdominal weight gain that doesn’t track intake, liver enzymes that run slightly high without a clear explanation, the fatty liver finding on ultrasound — these can all trace back to impaired fat export when PC is low. The liver processes fat normally; the failure is at the export step, where VLDL assembly requires PC.

Bile quality depends on PC, and so does fat-soluble vitamin absorption. PC is a structural component of bile: it solubilizes cholesterol within bile and protects bile duct epithelium. (It is not a precursor to bile salts, which are synthesized from cholesterol via CYP7A1 — a clinically meaningful distinction.) When PC drops, bile composition shifts. Fat-soluble vitamins — A, D, E, K — require functioning bile for absorption. A vitamin D level that stays flat despite supplementation is often a transport problem before it’s a deficit problem.

If sun is your primary vitamin D source, the bottleneck shifts upstream. Sun-derived D3 is synthesized in the skin and enters circulation directly, bypassing the gut — bile quality doesn’t factor in. The bottleneck is 25-hydroxylation: the conversion step that happens in the liver and produces the storage form your lab measures. Hepatic steatosis impairs that step. You can get intentional outdoor sun all summer and still test low in 25(OH)D. The flat reading is a conversion problem: the liver converting sun-derived D3 is already compromised. The fatty liver and the flat vitamin D trace back to the same upstream problem.

The PEMT rs7946 variant narrows the margin further. You may carry a loss-of-function polymorphism that reduces endogenous PC synthesis even before menopause. Post-menopause, that’s a double hit: estrogen already withdrawn, baseline PEMT capacity already lower. Repeated deficiency findings despite consistent intake, or a history of needing more nutritional support than seems warranted, can reflect this variant.

Cell membrane integrity depends on PC at every level. Phosphatidylcholine is the primary structural lipid in every cell membrane — not just hepatocytes. Receptor sensitivity, mitochondrial function, intracellular signaling all depend on membrane quality. PC deficit post-menopause doesn’t only affect liver fat export and bile; it affects how reliably every cell does its job, including the cells involved in the neurological and metabolic patterns that often cluster in this picture.

None of these variables appear in the standard fat-soluble vitamin or liver-support protocol.

Why Increasing the Dose Doesn’t Fix It

When vitamin D stays low, the standard escalation is a higher dose, a better-absorbed form (D3+K2 in oil-based softgels), or bile acid support. Correcting supplement form has value in isolation — a poorly absorbed D3 is worth addressing. But when the upstream problem is PC deficit and impaired bile quality, increasing the dose means adding more fat-soluble nutrient to a system that still can’t deliver it to tissue. The transport problem doesn’t resolve with more substrate.

Choline supplementation addresses the mechanism more directly. Form matters, and so does TMAO. Gut bacteria convert dietary choline to trimethylamine (TMA), which the liver oxidizes to TMAO, a compound associated with elevated cardiovascular risk. Post-menopausal women already carry an elevated cardiovascular risk profile. Supplemental choline salts (choline bitartrate, CDP-choline) present more substrate for TMA conversion than food-derived phosphatidylcholine. Food-first — eggs, liver, fatty fish — is the more conservative starting point: it provides PC in a form less readily converted by gut bacteria, and it comes with co-factors that isolated choline supplementation doesn’t.

What the Signal Means

The pattern — vitamins that don’t move, a liver that runs reluctantly, abdominal weight gain that doesn’t track intake — is estrogen-withdrawal physiology appearing as a nutritional problem. The question this pattern is asking: what was estrogen providing that the protocol assumed would always be there?

PEMT activity is one answer. The phosphatidylcholine it produced underwrote fat export from the liver, bile function, and cell membrane quality in ways that dietary intake never fully had to compensate for before. When estrogen withdrew, that underwriting disappeared — without a clinical marker most practitioners are tracking.

More supplementation runs against the same upstream obstacle. What needs to change is the metabolic context that makes fat-soluble nutrients transportable in the first place.

What does your liver’s operating environment need before the vitamins you’re taking can actually land?

What You Can Check Before Spending Anything

Start by identifying your primary vitamin D source — supplements or sun. The check runs differently depending on which one applies.

If you supplement: first, do you take D consistently with a fat-containing meal, or often on an empty stomach? Fat-free intake can mimic an absorption problem — correct that first before drawing further conclusions. Then ask whether your levels have moved at all across multiple draws. A modest rise that stalls at sub-optimal points toward a dosing or form question. A level that doesn’t move despite months of supplementation with adequate doses, taken consistently with dietary fat points toward an upstream absorption block — the bile quality and PC terrain this piece describes.

If you rely primarily on sun — intentional outdoor time, not incidental exposure — and your 25(OH)D still runs low, that flat reading is pointing somewhere different. Sun-derived D3 bypasses the gut entirely; bile is irrelevant for this pathway. The bottleneck is the liver: the 25-hydroxylation step that produces the storage form your lab measures. Hepatic steatosis impairs that conversion. Flat vitamin D in someone getting real outdoor sun is a liver signal. The liver failing to ship fat and the liver failing to convert D3 trace back to the same terrain.

What Working With Me Looks Like For This

In my practice, the PEMT-absorption picture shows up as a cluster: flat vitamin D despite supplementation, liver function sluggish within normal limits, abdominal fat accumulation that doesn’t match intake, and usually a history of nutritional approaches that worked before menopause and stopped working after. The intake maps three things specifically: the liver’s actual functional state beyond what reference ranges report, what the dietary choline sources look like and what the gut is doing with them, and whether the fat-soluble vitamin protocol is working with bile function or moving past it. On the structural side, thoracolumbar mechanics and diaphragm mobility matter here: hepatic portal circulation is pressure-dependent, and restricted fascial planes through the liver bed can compound impaired fat export independently of the biochemistry. That upstream-first order of operations is where the Vital Clarity Code becomes directly relevant: the terrain driving the absorption problem has to be addressed before anything else can land. A Vital Signal Check maps what the labs and the pattern are actually reporting — available in person or by virtual consult. If the structural layer is active — diaphragm, liver mobility, thoracolumbar bracing — a Midlife Body Reset addresses that once the terrain is mapped.

Fat-Soluble Vitamin Absorption in Menopause: Common Questions

Why does fatty liver develop in menopause even with a good diet? Fatty liver develops when the liver can’t export fat efficiently, and fat export requires phosphatidylcholine (PC). PC is synthesized by the PEMT enzyme, which is upregulated by estrogen. Post-menopause, PEMT activity drops with estrogen, PC production decreases, and fat accumulates in the liver because VLDL assembly fails. The driver is export capacity — the liver’s ability to package and ship fat as VLDL, a process estrogen was maintaining through PEMT.

How can I tell if my vitamin D is low because of a PEMT issue or because I’m not taking enough? If levels rise modestly with supplementation but plateau below optimal, that’s more consistent with a dosing or form question. If levels stay essentially flat across months of supplementation at adequate doses, taken consistently with dietary fat, that flat non-response points toward an upstream transport problem: impaired bile quality or PC deficit.

Is it safe to take choline supplements post-menopause? Food-first is the more conservative approach: eggs, liver, and fatty fish provide phosphatidylcholine in a form that produces less TMAO than supplemental choline salts. TMAO is associated with cardiovascular risk, and post-menopausal women already carry an elevated baseline. Supplemental choline isn’t off the table, but the form matters, and it works best when gut ecology isn’t converting large amounts of dietary choline to trimethylamine. The fuller picture warrants a practitioner who can hold both the absorption terrain and the cardiovascular context at once.

If this sounds like you — you’ve done the protocols, tried the tools, and your body keeps sending the same signal — book a Vital Signal Check. One session to decode what your body is actually reporting, and what needs to be in place before the interventions start working.